| Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
| P2RY14 |
purinergic receptor P2Y, G-protein coupled, 14, transcript variant 2 |
FXC00001
|
FHC00001
|
FNC00001N
|
FNC00001C
|
| DRD1 |
dopamine receptor D1 |
FXC00007
|
FHC00007
|
FNC00007N
|
FNC00007C
|
| GPRIN1 |
G protein regulated inducer of neurite outgrowth 1 |
FXC00296
|
FHC00296
|
FNC00296N
|
FNC00296C
|
| GPR83 |
G protein-coupled receptor 83 |
FXC00859
|
FHC00859
|
FNC00859N
|
FNC00859C
|
| GRIN3A |
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A |
FXC01187
|
FHC01187
|
FNC01187N
|
FNC01187C
|
| DHX8 |
DEAH (Asp-Glu-Ala-His) box polypeptide 8, transcript variant 1 |
FXC01202
|
FHC01202
|
FNC01202N
|
FNC01202C
|
| GABBR2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
FXC01238
|
FHC01238
|
FNC01238N
|
FNC01238C
|
| GRIK4 |
glutamate receptor, ionotropic, kainate 4, transcript variant 2 |
FXC01266
|
FHC01266
|
FNC01266N
|
FNC01266C
|
| THRB |
thyroid hormone receptor, beta, transcript variant 1 |
FXC01325
|
FHC01325
|
FNC01325N
|
FNC01325C
|
| GABRB2 |
gamma-aminobutyric acid (GABA) A receptor, beta 2, transcript variant 2 |
FXC01333
|
FHC01333
|
FNC01333N
|
FNC01333C
|
| GRIA3 |
glutamate receptor, ionotropic, AMPA 3, transcript variant 1 |
FXC01359
|
FHC01359
|
FNC01359N
|
FNC01359C
|
| GABRA2 |
gamma-aminobutyric acid (GABA) A receptor, alpha 2, transcript variant 1 |
FXC01373
|
FHC01373
|
FNC01373N
|
FNC01373C
|
| SSTR1 |
somatostatin receptor 1 |
FXC01392
|
FHC01392
|
FNC01392N
|
FNC01392C
|
| APLNR |
apelin receptor, transcript variant 1 |
FXC01405
|
FHC01405
|
FNC01405N
|
FNC01405C
|
| GRIA2 |
glutamate receptor, ionotropic, AMPA 2, transcript variant 1 |
FXC01427
|
FHC01427
|
FNC01427N
|
FNC01427C
|
| GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A, transcript variant 2 |
FXC01444
|
FHC01444
|
FNC01444N
|
FNC01444C
|
| GABRD |
gamma-aminobutyric acid (GABA) A receptor, delta |
FXC01489
|
FHC01489
|
FNC01489N
|
FNC01489C
|
| SSTR2 |
somatostatin receptor 2 |
FXC01491
|
FHC01491
|
FNC01491N
|
FNC01491C
|
| CHRM1 |
cholinergic receptor, muscarinic 1 |
FXC01507
|
FHC01507
|
FNC01507N
|
FNC01507C
|
| DRD2 |
dopamine receptor D2, transcript variant 1 |
FXC01519
|
FHC01519
|
FNC01519N
|
FNC01519C
|
| S1PR1 |
sphingosine-1-phosphate receptor 1 |
FXC01528
|
FHC01528
|
FNC01528N
|
FNC01528C
|
| TSHR |
thyroid stimulating hormone receptor, transcript variant 1 |
FXC01753
|
FHC01753
|
FNC01753N
|
FNC01753C
|
| GABRB1 |
gamma-aminobutyric acid (GABA) A receptor, beta 1 |
FXC01799
|
FHC01799
|
FNC01799N
|
FNC01799C
|
| S1PR5 |
sphingosine-1-phosphate receptor 5, transcript variant 1 |
|
FHC01802
|
FNC01802N
|
FNC01802C
|
| S1PR3 |
sphingosine-1-phosphate receptor 3 |
FXC01830
|
FHC01830
|
FNC01830N
|
FNC01830C
|
| TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
FXC01880
|
FHC01880
|
FNC01880N
|
FNC01880C
|
| GRM4 |
glutamate receptor, metabotropic 4, transcript variant 1 |
FXC01884
|
FHC01884
|
FNC01884N
|
FNC01884C
|
| EDNRB |
endothelin receptor type B, transcript variant 1 |
FXC02116
|
FHC02116
|
FNC02116N
|
FNC02116C
|
| MCHR1 |
melanin-concentrating hormone receptor 1 |
FXC02170
|
FHC02170
|
FNC02170N
|
FNC02170C
|
| P2RY13 |
purinergic receptor P2Y, G-protein coupled, 13 |
FXC02278
|
FHC02278
|
FNC02278N
|
FNC02278C
|
| P2RY10 |
purinergic receptor P2Y, G-protein coupled, 10, transcript variant 1 |
FXC02280
|
FHC02280
|
FNC02280N
|
FNC02280C
|
| LPAR6 |
lysophosphatidic acid receptor 6, transcript variant 1 |
FXC02281
|
FHC02281
|
FNC02281N
|
FNC02281C
|
| FPR1 |
formyl peptide receptor 1, transcript variant 2 |
FXC02286
|
FHC02286
|
FNC02286N
|
FNC02286C
|
| FPR3 |
formyl peptide receptor 3 |
FXC02287
|
FHC02287
|
FNC02287N
|
FNC02287C
|
| AGTR1 |
angiotensin II receptor, type 1, transcript variant 1 |
FXC02288
|
FHC02288
|
FNC02288N
|
FNC02288C
|
| CNR2 |
cannabinoid receptor 2 (macrophage) |
FXC02289
|
FHC02289
|
FNC02289N
|
FNC02289C
|
| AGTR2 |
angiotensin II receptor, type 2 |
FXC02290
|
FHC02290
|
FNC02290N
|
FNC02290C
|
| HTR1E |
5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled |
FXC02291
|
FHC02291
|
FNC02291N
|
FNC02291C
|
| HCRTR2 |
hypocretin (orexin) receptor 2 |
FXC02305
|
FHC02305
|
FNC02305N
|
FNC02305C
|
| FSHB |
follicle stimulating hormone, beta polypeptide, transcript variant 1 |
FXC02314
|
FHC02314
|
FNC02314N
|
FNC02314C
|
| OPRD1 |
opioid receptor, delta 1 |
FXC02316
|
FHC02316
|
FNC02316N
|
FNC02316C
|
| GLP1R |
glucagon-like peptide 1 receptor |
FXC02317
|
FHC02317
|
FNC02317N
|
FNC02317C
|
| MLNR |
motilin receptor |
FXC02452
|
FHC02452
|
FNC02452N
|
FNC02452C
|
| HCRTR1 |
hypocretin (orexin) receptor 1 |
FXC02641
|
FHC02641
|
FNC02641N
|
FNC02641C
|
| PRLR |
prolactin receptor, transcript variant 1 |
FXC02789
|
FHC02789
|
FNC02789N
|
FNC02789C
|
| SSTR3 |
somatostatin receptor 3, transcript variant 1 |
FXC02861
|
FHC02861
|
FNC02861N
|
FNC02861C
|
| MC2R |
melanocortin 2 receptor (adrenocorticotropic hormone) |
FXC03022
|
FHC03022
|
FNC03022N
|
FNC03022C
|
| NPY2R |
neuropeptide Y receptor Y2 |
FXC03041
|
FHC03041
|
FNC03041N
|
FNC03041C
|
| NPY5R |
neuropeptide Y receptor Y5 |
FXC03050
|
FHC03050
|
FNC03050N
|
FNC03050C
|
| CHRM2 |
cholinergic receptor, muscarinic 2, transcript variant 4 |
FXC03057
|
FHC03057
|
FNC03057N
|
FNC03057C
|
| LEP |
leptin |
FXC03079
|
FHC03079
|
FNC03079N
|
FNC03079C
|
| ADORA1 |
adenosine A1 receptor, transcript variant 1 |
FXC03111
|
FHC03111
|
FNC03111N
|
FNC03111C
|
| ADORA2B |
adenosine A2b receptor |
FXC03114
|
FHC03114
|
FNC03114N
|
FNC03114C
|
| PTGFR |
prostaglandin F receptor (FP), transcript variant 1 |
FXC03121
|
FHC03121
|
FNC03121N
|
FNC03121C
|
| PTGDR |
prostaglandin D2 receptor (DP), transcript variant 1 |
FXC03122
|
FHC03122
|
FNC03122N
|
FNC03122C
|
| F2RL2 |
coagulation factor II (thrombin) receptor-like 2, transcript variant 1 |
FXC03126
|
FHC03126
|
FNC03126N
|
FNC03126C
|
| PTGIR |
prostaglandin I2 (prostacyclin) receptor (IP) |
FXC03129
|
FHC03129
|
FNC03129N
|
FNC03129C
|
| BDKRB2 |
bradykinin receptor B2 |
FXC03132
|
FHC03132
|
FNC03132N
|
FNC03132C
|
| HTR5A |
5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled |
FXC03137
|
FHC03137
|
FNC03137N
|
FNC03137C
|
| AVPR1A |
arginine vasopressin receptor 1A |
FXC03138
|
FHC03138
|
FNC03138N
|
FNC03138C
|
| PTAFR |
platelet-activating factor receptor, transcript variant 3 |
FXC03342
|
FHC03342
|
FNC03342N
|
FNC03342C
|
| HTR1F |
5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled |
FXC03353
|
FHC03353
|
FNC03353N
|
FNC03353C
|
| P2RY1 |
purinergic receptor P2Y, G-protein coupled, 1 |
FXC03355
|
FHC03355
|
FNC03355N
|
FNC03355C
|
| NPY4R |
neuropeptide Y receptor Y4, transcript variant 1 |
FXC03357
|
FHC03357
|
FNC03357N
|
FNC03357C
|
| P2RY2 |
purinergic receptor P2Y, G-protein coupled, 2, transcript variant 2 |
FXC03359
|
FHC03359
|
FNC03359N
|
FNC03359C
|
| HTR1D |
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
FXC03360
|
FHC03360
|
FNC03360N
|
FNC03360C
|
| HTR1B |
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
FXC03365
|
FHC03365
|
FNC03365N
|
FNC03365C
|
| HTR1A |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
FXC03369
|
FHC03369
|
FNC03369N
|
FNC03369C
|
| ADRA2A |
adrenoceptor alpha 2A |
FXC03371
|
FHC03371
|
FNC03371N
|
FNC03371C
|
| AVPR2 |
arginine vasopressin receptor 2, transcript variant 1 |
FXC03500
|
FHC03500
|
FNC03500N
|
FNC03500C
|
| SCTR |
secretin receptor |
FXC03512
|
FHC03512
|
FNC03512N
|
FNC03512C
|
| EDNRA |
endothelin receptor type A, transcript variant 1 |
FXC03517
|
FHC03517
|
FNC03517N
|
FNC03517C
|
| ADORA3 |
adenosine A3 receptor, transcript variant A |
FXC03559
|
FHC03559
|
FNC03559N
|
FNC03559C
|
| GABBR1 |
gamma-aminobutyric acid (GABA) B receptor, 1, transcript variant 1 |
FXC03778
|
FHC03778
|
FNC03778N
|
FNC03778C
|
| GRIA1 |
glutamate receptor, ionotropic, AMPA 1, transcript variant 1 |
FXC03786
|
FHC03786
|
FNC03786N
|
FNC03786C
|
| GRM8 |
glutamate receptor, metabotropic 8, transcript variant 2 |
FXC03787
|
FHC03787
|
FNC03787N
|
FNC03787C
|
| ADRA2B |
adrenoceptor alpha 2B |
FXC03869
|
FHC03869
|
FNC03869N
|
FNC03869C
|
| DRD3 |
dopamine receptor D3, transcript variant a |
FXC03913
|
FHC03913
|
FNC03913N
|
FNC03913C
|
| CCKBR |
cholecystokinin B receptor |
FXC03920
|
FHC03920
|
FNC03920N
|
FNC03920C
|
| HTR2C |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled, transcript variant 2 |
FXC03963
|
FHC03963
|
FNC03963N
|
FNC03963C
|
| CCKAR |
cholecystokinin A receptor |
FXC03970
|
FHC03970
|
FNC03970N
|
FNC03970C
|
| ADORA2A |
adenosine A2a receptor, transcript variant 3 |
FXC04058
|
FHC04058
|
FNC04058N
|
FNC04058C
|
| C3AR1 |
complement component 3a receptor 1 |
FXC04389
|
FHC04389
|
FNC04389N
|
FNC04389C
|
| CHRNA9 |
cholinergic receptor, nicotinic, alpha 9 (neuronal) |
FXC04564
|
FHC04564
|
FNC04564N
|
FNC04564C
|
| GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
FXC05358
|
FHC05358
|
FNC05358N
|
FNC05358C
|
| GRM1 |
glutamate receptor, metabotropic 1, transcript variant 3 |
FXC05363
|
FHC05363
|
FNC05363N
|
FNC05363C
|
| P2RX4 |
purinergic receptor P2X, ligand gated ion channel, 4, transcript variant 2 |
FXC06254
|
FHC06254
|
FNC06254N
|
FNC06254C
|
| P2RX6 |
purinergic receptor P2X, ligand gated ion channel, 6, transcript variant 1 |
FXC06257
|
FHC06257
|
FNC06257N
|
FNC06257C
|
| RXFP2 |
relaxin/insulin-like family peptide receptor 2, transcript variant 1 |
FXC06715
|
FHC06715
|
FNC06715N
|
FNC06715C
|
| SSTR5 |
somatostatin receptor 5, transcript variant 1 |
FXC06999
|
FHC06999
|
FNC06999N
|
FNC06999C
|
| TAAR2 |
trace amine associated receptor 2, transcript variant 1 |
FXC07049
|
FHC07049
|
FNC07049N
|
FNC07049C
|
| TRPV1 |
transient receptor potential cation channel, subfamily V, member 1, transcript variant 2 |
FXC07221
|
FHC07221
|
FNC07221N
|
FNC07221C
|
| TSPO |
translocator protein (18kDa), transcript variant PBR |
FXC07231
|
FHC07231
|
FNC07231N
|
FNC07231C
|
| MTNR1A |
melatonin receptor 1A |
FXC07731
|
FHC07731
|
FNC07731N
|
FNC07731C
|
| THRA |
thyroid hormone receptor, alpha, transcript variant 2 |
FXC07745
|
FHC07745
|
FNC07745N
|
FNC07745C
|
| GRID2 |
glutamate receptor, ionotropic, delta 2, transcript variant 1 |
FXC07784
|
FHC07784
|
FNC07784N
|
FNC07784C
|
| CHGA |
chromogranin A, transcript variant 1 |
FXC07948
|
FHC07948
|
FNC07948N
|
FNC07948C
|
| CHRNB1 |
cholinergic receptor, nicotinic, beta 1 (muscle) |
FXC08549
|
FHC08549
|
FNC08549N
|
FNC08549C
|
| UBD |
ubiquitin D |
FXC08635
|
FHC08635
|
FNC08635N
|
FNC08635C
|
| CTSG |
cathepsin G |
FXC08744
|
FHC08744
|
FNC08744N
|
FNC08744C
|
| GZMA |
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
FXC08808
|
FHC08808
|
FNC08808N
|
FNC08808C
|
| PRL |
prolactin, transcript variant 1 |
FXC08822
|
FHC08822
|
FNC08822N
|
FNC08822C
|
| F2RL1 |
F2R like trypsin receptor 1 |
FXC08944
|
FHC08944
|
FNC08944N
|
FNC08944C
|
| FPR2 |
formyl peptide receptor 2, transcript variant 1 |
FXC09276
|
FHC09276
|
FNC09276N
|
FNC09276C
|
| GABRA1 |
gamma-aminobutyric acid (GABA) A receptor, alpha 1, transcript variant 1 |
FXC09343
|
FHC09343
|
FNC09343N
|
FNC09343C
|
| GABRG1 |
gamma-aminobutyric acid (GABA) A receptor, gamma 1 |
FXC09367
|
FHC09367
|
FNC09367N
|
FNC09367C
|
| GLRB |
glycine receptor, beta, transcript variant 1 |
FXC09438
|
FHC09438
|
FNC09438N
|
FNC09438C
|
| CHRNA5 |
cholinergic receptor, nicotinic, alpha 5 (neuronal), transcript variant 1 |
FXC09483
|
FHC09483
|
FNC09483N
|
FNC09483C
|
| BDKRB1 |
bradykinin receptor B1 |
FXC09533
|
FHC09533
|
FNC09533N
|
FNC09533C
|
| GLRA3 |
glycine receptor, alpha 3, transcript variant 1 |
FXC09603
|
FHC09603
|
FNC09603N
|
FNC09603C
|
| F2R |
coagulation factor II thrombin receptor, transcript variant 1 |
FXC09792
|
FHC09792
|
FNC09792N
|
FNC09792C
|
| P2RX7 |
purinergic receptor P2X, ligand-gated ion channel, 7, transcript variant 1 |
FXC09980
|
FHC09980
|
FNC09980N
|
FNC09980C
|
| GABRA3 |
gamma-aminobutyric acid (GABA) A receptor, alpha 3 |
FXC10228
|
FHC10228
|
FNC10228N
|
FNC10228C
|
| CSH1 |
chorionic somatomammotropin hormone 1 (placental lactogen) |
FXC10446
|
FHC10446
|
FNC10446N
|
FNC10446C
|
| NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor), transcript variant 1 |
FXC10483
|
FHC10483
|
FNC10483N
|
FNC10483C
|
| CNR1 |
cannabinoid receptor 1 (brain), transcript variant 1 |
FXC10491
|
FHC10491
|
FNC10491N
|
FNC10491C
|
| P2RX5 |
purinergic receptor P2X, ligand gated ion channel, 5, transcript variant 1 |
FXC10528
|
FHC10528
|
FNC10528N
|
FNC10528C
|
| DRD5 |
dopamine receptor D5 |
FXC10652
|
FHC10652
|
FNC10652N
|
FNC10652C
|
| PRSS1 |
protease, serine, 1 (trypsin 1) |
FXC10667
|
FHC10667
|
FNC10667N
|
FNC10667C
|
| PRSS3 |
protease, serine, 3, transcript variant 1 |
FXC10679
|
FHC10679
|
FNC10679N
|
FNC10679C
|
| CHRM3 |
cholinergic receptor, muscarinic 3 |
FXC10778
|
FHC10778
|
FNC10778N
|
FNC10778C
|
| NTSR1 |
neurotensin receptor 1 (high affinity) |
FXC10893
|
FHC10893
|
FNC10893N
|
FNC10893C
|
| BRS3 |
bombesin-like receptor 3 |
FXC10903
|
FHC10903
|
FNC10903N
|
FNC10903C
|
| CHRNA10 |
cholinergic receptor, nicotinic, alpha 10 (neuronal), transcript variant 1 |
FXC10912
|
FHC10912
|
FNC10912N
|
FNC10912C
|
| CHRNA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal), transcript variant 1 |
FXC11017
|
FHC11017
|
FNC11017N
|
FNC11017C
|
| LPAR1 |
lysophosphatidic acid receptor 1, transcript variant 1 |
FXC11200
|
FHC11200
|
FNC11200N
|
FNC11200C
|
| NMUR1 |
neuromedin U receptor 1 |
FXC11244
|
FHC11244
|
FNC11244N
|
FNC11244C
|
| MC3R |
melanocortin 3 receptor |
FXC11279
|
FHC11279
|
FNC11279N
|
FNC11279C
|
| TAAR6 |
trace amine associated receptor 6 |
FXC11302
|
FHC11302
|
FNC11302N
|
FNC11302C
|
| TAAR8 |
trace amine associated receptor 8 |
FXC11303
|
FHC11303
|
FNC11303N
|
FNC11303C
|
| OPRK1 |
opioid receptor, kappa 1, transcript variant 1 |
FXC11358
|
FHC11358
|
FNC11358N
|
FNC11358C
|
| HTR6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
FXC11383
|
FHC11383
|
FNC11383N
|
FNC11383C
|
| AVPR1B |
arginine vasopressin receptor 1B |
FXC11387
|
FHC11387
|
FNC11387N
|
FNC11387C
|
| GLRA2 |
glycine receptor, alpha 2, transcript variant 1 |
FXC11507
|
FHC11507
|
FNC11507N
|
FNC11507C
|
| GABRB3 |
gamma-aminobutyric acid (GABA) A receptor, beta 3, transcript variant 1 |
FXC11524
|
FHC11524
|
FNC11524N
|
FNC11524C
|
| PTGER3 |
prostaglandin E receptor 3 (subtype EP3) |
FXC11666
|
FHC11666
|
FNC11666N
|
FNC11666C
|
| LTB4R2 |
leukotriene B4 receptor 2, transcript variant 1 |
FXC11715
|
FHC11715
|
FNC11715N
|
FNC11715C
|
| GRIA1 |
glutamate receptor, ionotropic, AMPA 1, transcript variant 2 |
FXC11832
|
FHC11832
|
FNC11832N
|
FNC11832C
|
| GHSR |
growth hormone secretagogue receptor, transcript variant 1a |
FXC11922
|
FHC11922
|
FNC11922N
|
FNC11922C
|
| OPRM1 |
opioid receptor, mu 1 |
FXC11924
|
FHC11924
|
FNC11924N
|
FNC11924C
|
| DHX34 |
DEAH (Asp-Glu-Ala-His) box polypeptide 34 |
FXC12090
|
FHC12090
|
FNC12090N
|
FNC12090C
|
| CGA |
glycoprotein hormones, alpha polypeptide, transcript variant 2 |
FXC12142
|
FHC12142
|
FNC12142N
|
FNC12142C
|
| GABRE |
gamma-aminobutyric acid (GABA) A receptor, epsilon |
FXC12250
|
FHC12250
|
FNC12250N
|
FNC12250C
|
| RXFP1 |
relaxin/insulin-like family peptide receptor 1, transcript variant 1 |
FXC12365
|
FHC12365
|
FNC12365N
|
FNC12365C
|
| HRH4 |
histamine receptor H4, transcript variant 1 |
FXC12552
|
FHC12552
|
FNC12552N
|
FNC12552C
|
| PARD3 |
par-3 family cell polarity regulator, transcript variant 2 |
FXC12690
|
FHC12690
|
FNC12690N
|
FNC12690C
|
| GRIK2 |
glutamate receptor, ionotropic, kainate 2 |
FXC15713
|
FHC15713
|
FNC15713N
|
FNC15713C
|
| GABRA6 |
gamma-aminobutyric acid (GABA) A receptor, alpha 6 |
FXC15898
|
FHC15898
|
FNC15898N
|
FNC15898C
|
| GABRA4 |
gamma-aminobutyric acid (GABA) A receptor, alpha 4, transcript variant 1 |
FXC16529
|
FHC16529
|
FNC16529N
|
FNC16529C
|
| LEPR |
leptin receptor, transcript variant 1
|
FXC20344
|
FHC20344
|
|
|
| PTGER3 |
prostaglandin E receptor 3 (subtype EP3), transcript variant 8 |
FXC20366
|
FHC20366
|
FNC20366N
|
FNC20366C
|
| TSHB |
thyroid stimulating hormone, beta, transcript variant 1 |
FXC20489
|
FHC20489
|
FNC20489N
|
FNC20489C
|
| CHRNB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
FXC20591
|
FHC20591
|
FNC20591N
|
FNC20591C
|
| RXFP4 |
relaxin/insulin-like family peptide receptor 4 |
FXC20620
|
FHC20620
|
FNC20620N
|
FNC20620C
|
| LHCGR |
luteinizing hormone/choriogonadotropin receptor |
FXC21004
|
FHC21004
|
FNC21004N
|
FNC21004C
|
| FSHR |
follicle stimulating hormone receptor, transcript variant 1 |
FXC21005
|
FHC21005
|
FNC21005N
|
FNC21005C
|
| TACR1 |
tachykinin receptor 1, transcript variant long |
FXC21063
|
FHC21063
|
FNC21063N
|
FNC21063C
|
| CHRNA1 |
cholinergic receptor, nicotinic, alpha 1 (muscle), transcript variant 1
|
FXC21232
|
FHC21232
|
|
|
| CHRND |
cholinergic receptor, nicotinic, delta (muscle), transcript variant 1 |
FXC21373
|
FHC21373
|
FNC21373N
|
FNC21373C
|
| PTH1R |
parathyroid hormone 1 receptor, transcript variant 1 |
FXC21519
|
FHC21519
|
FNC21519N
|
FNC21519C
|
| GNRHR |
gonadotropin-releasing hormone receptor, transcript variant 1 |
FXC21930
|
FHC21930
|
FNC21930N
|
FNC21930C
|
| RXFP3 |
relaxin/insulin like family peptide receptor 3 |
FXC22137
|
FHC22137
|
FNC22137N
|
FNC22137C
|
| HTR4 |
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled, transcript variant b |
FXC22341
|
FHC22341
|
FNC22341N
|
FNC22341C
|
| HTR4 |
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled, transcript variant a |
FXC22342
|
FHC22342
|
FNC22342N
|
FNC22342C
|
| GLRA1 |
glycine receptor, alpha 1, transcript variant 2 |
FXC22358
|
FHC22358
|
FNC22358N
|
FNC22358C
|
| HRH2 |
histamine receptor H2, transcript variant 1 |
FXC22391
|
FHC22391
|
FNC22391N
|
FNC22391C
|
| TAAR5 |
trace amine associated receptor 5 |
FXC22757
|
FHC22757
|
FNC22757N
|
FNC22757C
|
| TAAR1 |
trace amine associated receptor 1 |
FXC22758
|
FHC22758
|
FNC22758N
|
FNC22758C
|
| GHRHR |
growth hormone releasing hormone receptor |
FXC22893
|
FHC22893
|
FNC22893N
|
FNC22893C
|
| CHRNA2 |
cholinergic receptor, nicotinic, alpha 2 (neuronal), transcript variant 1 |
FXC23226
|
FHC23226
|
FNC23226N
|
FNC23226C
|
| CHRNB3 |
cholinergic receptor, nicotinic, beta 3 (neuronal) |
FXC23258
|
FHC23258
|
FNC23258N
|
FNC23258C
|
| CHRNA6 |
cholinergic receptor, nicotinic, alpha 6 (neuronal), transcript variant 1 |
FXC23259
|
FHC23259
|
FNC23259N
|
FNC23259C
|
| TRHR |
thyrotropin-releasing hormone receptor |
FXC23362
|
FHC23362
|
FNC23362N
|
FNC23362C
|
| HTR7 |
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled, transcript variant d |
FXC23935
|
FHC23935
|
FNC23935N
|
FNC23935C
|
| DRD4 |
dopamine receptor D4 |
FXC24098
|
FHC24098
|
FNC24098N
|
FNC24098C
|
| CHRNA3 |
cholinergic receptor, nicotinic, alpha 3 (neuronal), transcript variant 1 |
FXC25478
|
FHC25478
|
FNC25478N
|
FNC25478C
|
| CHRNB4 |
cholinergic receptor, nicotinic, beta 4 (neuronal), transcript variant 1 |
FXC25479
|
FHC25479
|
FNC25479N
|
FNC25479C
|
| P2RX1 |
purinergic receptor P2X, ligand gated ion channel, 1 |
FXC25833
|
FHC25833
|
FNC25833N
|
FNC25833C
|
| CHRNE |
cholinergic receptor, nicotinic, epsilon (muscle) |
FXC25849
|
FHC25849
|
FNC25849N
|
FNC25849C
|
| UTS2R |
urotensin 2 receptor |
FXC26230
|
FHC26230
|
FNC26230N
|
FNC26230C
|
| HRH4 |
histamine receptor H4, transcript variant 2 |
FXC26277
|
FHC26277
|
FNC26277N
|
FNC26277C
|
| GALR1 |
galanin receptor 1 |
FXC26336
|
FHC26336
|
FNC26336N
|
FNC26336C
|
| P2RY11 |
purinergic receptor P2Y, G-protein coupled, 11 |
FXC26457
|
FHC26457
|
FNC26457N
|
FNC26457C
|
| LPAR2 |
lysophosphatidic acid receptor 2 |
FXC26554
|
FHC26554
|
FNC26554N
|
FNC26554C
|
| GRIN2D |
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
FXC26720
|
FHC26720
|
FNC26720N
|
FNC26720C
|
| ADRA1D |
adrenoceptor alpha 1D |
FXC26901
|
FHC26901
|
FNC26901N
|
FNC26901C
|
| HRH3 |
histamine receptor H3 |
FXC27098
|
FHC27098
|
FNC27098N
|
FNC27098C
|
| OPRL1 |
opiate receptor-like 1, transcript variant 2 |
FXC27117
|
FHC27117
|
FNC27117N
|
FNC27117C
|
| GRPR |
gastrin-releasing peptide receptor |
FXC27311
|
FHC27311
|
FNC27311N
|
FNC27311C
|
| LPAR4 |
lysophosphatidic acid receptor 4, transcript variant 2 |
FXC27432
|
FHC27432
|
FNC27432N
|
FNC27432C
|
| GABRQ |
gamma-aminobutyric acid (GABA) A receptor, theta |
FXC27555
|
FHC27555
|
FNC27555N
|
FNC27555C
|
| CHRFAM7A |
CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion, transcript variant 1 |
FXC28291
|
FHC28291
|
FNC28291N
|
FNC28291C
|
| CHRFAM7A |
CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion, transcript variant 2 |
FXC28292
|
FHC28292
|
FNC28292N
|
FNC28292C
|
| CHRNG |
cholinergic receptor, nicotinic, gamma (muscle)
|
FXC28786
|
FHC28786
|
|
|
| GRIK1 |
glutamate receptor, ionotropic, kainate 1, transcript variant 2 |
FXC28833
|
FHC28833
|
FNC28833N
|
FNC28833C
|
| CHRM4 |
cholinergic receptor, muscarinic 4 |
FXC30477
|
FHC30477
|
FNC30477N
|
FNC30477C
|
| GABRA5 |
gamma-aminobutyric acid (GABA) A receptor, alpha 5, transcript variant 1 |
FXC30604
|
FHC30604
|
FNC30604N
|
FNC30604C
|
| GH2 |
growth hormone 2, transcript variant 1 |
FXC31562
|
FHC31562
|
FNC31562N
|
FNC31562C
|
| GH1 |
growth hormone 1, transcript variant 1 |
FXC31566
|
FHC31566
|
FNC31566N
|
FNC31566C
|
| GALR2 |
galanin receptor 2 |
FXC31570
|
FHC31570
|
FNC31570N
|
FNC31570C
|
| GALR3 |
galanin receptor 3 |
FXC31600
|
FHC31600
|
FNC31600N
|
FNC31600C
|
| F2 |
coagulation factor II (thrombin), transcript variant 1 |
FXC31633
|
FHC31633
|
FNC31633N
|
FNC31633C
|
